Scripps Florida Scientists Develop New Compound that Reverses Fatty Liver Disease

Thursday, December 20, 2012

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.

read more...